Douglas Joshua
- Hematology top 1%
- Multiple Myeloma Research and Treatments 36
- Immunology top 5%
- T-cell and B-cell Immunology 14
- Immunotherapy and Immune Responses 12
- Immune Cell Function and Interaction 9
- Oncology top 5%
- Peptidase Inhibition and Analysis 6
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 7
- Molecular Biology top 10%
- Protein Degradation and Inhibitors 7
-
- Monoclonal and Polyclonal Antibodies Research 10
- Co-authors
- John GibsonRoss BrownP. Joy HoHayley SuenJoy HoShihong YangChristian BryantDerek N.J. Hart
- Cited by
- HematologyImmunologyOncology
- Journals
- Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (1 paper)Blood (16 papers)
- Partner nations
- AustraliaUnited StatesSpain
In The Last Decade
Douglas Joshua
64 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 94
- Hematology 1.0k
- Immunology 548
- Oncology 679
- Genetics 179
- Molecular Biology 751
Countries citing papers authored by Douglas Joshua
This map shows the geographic impact of Douglas Joshua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Joshua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Joshua more than expected).
Fields of papers citing papers by Douglas Joshua
This network shows the impact of papers produced by Douglas Joshua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Joshua. The network helps show where Douglas Joshua may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Douglas Joshua, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 14 | |
| 4 | 2020 | 28 | |
| 5 | 2014 | 15 | |
| 6 | 2014 | 91 | |
| 7 | 2013 | 64 | |
| 8 | 2012 | 18 | |
| 9 | 2010 | 24 | |
| 10 | 2008 | 33 | |
| 11 | 2007 | 55 | |
| 12 | 2006 | 11 | |
| 13 | 2002 | 17 | |
| 14 | 1997 | 11 | |
| 15 | 1996 | 24 | |
| 16 | 1996 | 2 | |
| 17 | 1995 | 5 | |
| 18 | 1991 | 18 | |
| 19 | 1988 | 26 | |
| 20 | 1987 | 15 |
About Douglas Joshua
Douglas Joshua is a scholar working on Hematology, Immunology and Genetics, having authored 65 papers that have together received 1.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (36 papers), T-cell and B-cell Immunology (14 papers), Immunotherapy and Immune Responses (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Immune Cell Function and Interaction (9 papers), Chronic Lymphocytic Leukemia Research (7 papers), Protein Degradation and Inhibitors (7 papers) and Peptidase Inhibition and Analysis (6 papers). The work is most often cited by research in Hematology (1.0k citations), Immunology (548 citations) and Oncology (679 citations). Douglas Joshua has collaborated with scholars based in Australia, United States and Spain. Frequent co-authors include John Gibson, Ross Brown, P. Joy Ho, Hayley Suen, Joy Ho, Shihong Yang, Christian Bryant, Derek N.J. Hart, Daniel Sze and James Favaloro. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.